External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Infectious Disease ISIRV 2023
Roche and Genentech at

ISIRV 2023

May 03 - May 05
Seattle, USA
isirv.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Coming soon

Sign up or login to unlock the full suite of MEDICALLY features
May 3 / Roche and Genentech
Predictors of Influenza Outcomes in Natural Infections: A Post-Hoc Analysis of CAPSTONE-2 clinical trial
The objective of this poster was to understand the natural history of influenza in high-risk patients and assess the impact of baseline factors on expected clinical and virologic outcomes with antiviral therapy.
Infectious Disease Influenza Virus Infection ISIRV-2023

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.